Epidemiology of Neuroendocrine Neoplasms in the US
Dasari A, Wallace K, Halperin D, Maxwell J, Kunz P, Singh S, Chasen B, Yao J. Epidemiology of Neuroendocrine Neoplasms in the US. JAMA Network Open 2025, 8: e2515798. PMID: 40553474, PMCID: PMC12188367, DOI: 10.1001/jamanetworkopen.2025.15798.Peer-Reviewed Original ResearchConceptsDuration prevalenceIncidence rateNational Cancer Institute's SurveillanceNeuroendocrine neoplasmsOverall survivalNeuroendocrine tumorsAge-adjusted incidenceSurvival trends of patientsAnnual age-adjusted incidenceNeuroendocrine neoplasm casesCross-sectional studyHighest incidence ratePrimary siteTrends of patientsInstitute's SurveillanceMain OutcomesPrevalence of neuroendocrine neoplasmsSmall bowelPrimary site of originFactors associated with survivalDiagnosis of early stage diseasePractice patternsPancreatic neuroendocrine tumorsGastrointestinal neuroendocrine tumorsEarly stage disease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply